Terray's CTO, Narbe Mardirossian, was named to BioSpace's 2026 40 Under 40 list.  The list recognizes leaders for their innovation, impact, and commitment to improving outcomes for patients. 

Over the last six years, Narbe has built the AI and data backbone for EMMI, Terray’s integrated experimentation and chemistry-first AI platform for novel drug discovery and development. I

In just one example, under his leadership, the EMMI platform has generated more than 20 billion experimentally derived binding measurements, accelerating hit identification and powering the entire drug discovery process at Terray.

CTO, Narbe Mardirossian, Named 40 Under 40 Winner